Skip to main content

Table 1 Baseline information for women included in the discovery and replication steps

From: A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

 

Discovery

Replication

Benign tumors cohort I

Ovarian cancer cohort I

Endometrial cancer cohort I

Population controls I

Benign tumors cohort II

Ovarian cancer cohort II

Ovarian cancer cohort III

Endometrial cancer cohort

Population controls II

Number of women

150 (SAL1)

106 (SAL1)

74 (SU1)

399 (NSPHS)

76 (SU2)

160 (SU2)

120 (UU)

228 (UU)

57 (UU)

Age

Mean

59.8

61.2

59.84

49.3

60.8

61.8

60.9

66.8

57.3

Median

60

60

60

49

63

63

62

68

58

Range

16–88

28–88

29–86

14–94

22–88

19–87

21–86

29–90

18–86

SD

15.8

12.9

10.75974

20.3

14.5

11.9

12.9

10.5

14.2

P-value versus benign

NA

0.870

0.003665

2.22E−08

NA

0.868

0.937

0.001

0.163

Ethnicity

Caucasian

Caucasian

Caucasian

Caucasian

Caucasian

Caucasian

Caucasian

Caucasian

Caucasian

Stage

I (I/IA/IB)

 

46

50 (0/41/9)

  

35

10

109 (3/83/23)

 

II (II/IIA/IIB)

 

8

8 (8/0/0)

  

9

3

13 (12/0/1)

 

III (III/IIIA/IIIB/IIIC/IIIC1/IIIC2)

 

47

10 (0/2/2/0/2/4)

  

96

40

22 (1/4/4/5/1/7)

 

IV (IV/IVA/IVB)

 

5

6 (2/0/4)

  

19

24

11 (5/0/6)

 

Classification unvailable

     

1

43

73

Â